INTRODUCTION
Various in vitro studies indicate that human gamma globulin (FII),' particularly in an aggregated form A portion of this work appeared in abstract form in:
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1 Abbreviations tsed in this paper: aggEII, aggregated gamma globulin; aggHSA, aggregated human serum albumin; AS, ankylosing spondylitis; C, complement; C3, third component of complement; C4, fourth component of com-(aggF1I), can combine with rheumatoid factor (RF) to form a complex (1, 2) and to activate the blood complement (C) sequence (3, 4) , thereby releasing a variety of phlogistic mediators (5) . Since other studies have shown that synovial fluids derived from some patients with rheumatoid arthritis (RA) exhibit depressed levels of C (4, 6) and can contain aggFlI and RF (7) which is frequently in the form of intracellular immune complex-like inclusions containing C (8) , it has been postulated that aggFII may participate in the pathogenesis of rheumatoid synovial inflammation via humoral imnmune mechanisms (9) . Contrary to the foregoing, there has been no unequivocal demonstration that cell-mediated illmmuniity involv ing Fli is imiiplicated in the pathogenesis of rheumatoid inflammation. In particular, in vivo studies employilg delayed hypersensitivity skin responses to native-and( aggFII (10, 11) and the intra-articular injection of purified FII into human volunteers (12) , have not resolved this question. Because of controversial results derived from such in vivo studies (10) (11) (12) (13) others have relied oIn in vitro techniques, including in vitro lymphocyte transformation whiclh is known to be a reliable correlate of cell-mediated immuinity (14) , to investigate possible roles for Fli and RF in the pathogenesis of RA. Unfortunately, recent studies have reported that neither isolated FII (11, 15, 16) nor isolated RF (17) can consistently induce in vitro transformation of peripheral blood lymphocytes of subjects with RA. Thus, in contrast to the situation regarding humoral immunity, the majority of currently available evidence has not delineated a role for FIT in cell-mediated immunity in the pathogenesis of RA.
The present studies were suggested by observations that sonme circulating lymphocytes possess surface receptors for C-containing immune complexes (18) and, as reviewed above, that some RA synovial fluids contain complexes of aggFII with RF and/or C. Accordingly, the experiments to be described were designed to approximate in vivo circumstances by evaluating the blastogenic effect of aggFII and deaggregated FII (deagg FII) on peripheral blood lymphocytes in the presence of a source of C, namely fresh autologous plasma. The results of these studies demonstrate that in vitro lymphocyte transformation can be induced by aggFII under such conditions.
METHODS
Study groups. 12 patients with RA, 6 with ankylosing spondylitis (AS), 2 with systemic lupus erythematosus (SLE), and 7 normal subjects were studied. All RA patients had "classical" or "definite" diseases by criteria of the American Rheumatism Association (19) in plasma and FII-free fetal calf serum (FCS) were determined as described by Mayer (23) . The marked sensitivity of the CH50 assay to the presence of aggFII was utilized to ensure that batches of FII which had been deaggregated by centrifugation were indeed free of aggregates (3, 11) . Plasma concentrations of C3 were determined by single radial immunodiffusion, employing commercial immunoplates (Hyland Div., Travenol Laboratories, Inc.), containing 5 Al plasma/well. Studies of plasma levels of C3 were initiated on the day on which cultures were established for lymphocyte transformation, or, in a few instances, within 24 h, with samples which had been immediately frozen at -20°C. Reaction volumes for determination of C activation were identical to those usually employed in lymphocyte cultures and consisted of duplicate tubes containing 0.05 ml (200 ,ug) agg-or deaggFII in 0.2 ml plasma. After incubation at 37°C X 20 min, appropriate aliquots were withdrawn for C determinations. Results are expressed as the decrease of C concentration in plasma after addition of 200 ,g aggFII as compared to the simultaneously determined C value in a plasma aliquot to which 200 ug deaggFII had been added as a dilution control.
Leukocyte cuiltures. 50 ml of venous blood, containing 1,000 units preservative-free heparin (Connaught Medical Research Laboratories, Toronto, Canada), were obtained from each subject. Erythrocytes were usually sedimented by gravity at room temperature in an inverted syringe, but for some normal subjects several centrifugations at 75 g X 20 min were required. The leukocyte-rich supernatant plasma was centrifuged at 250 g X 10 min in glass tubes and the resultant cell pellet, after three washes in RPMI 1640 culture medium (Grand Island Biological Co.), was resuspended in sufficient RPMI 1640 to provide 5 X 105 small lymphocytes in 0.2 ml. Supernatant plasma was centrifuged once again at 1500 g X 10 min at 4°C before addition to autologous cultures and, when required in some experiments, heat inactivated at 56°C X 30 min in a water bath. FIT-free FCS (Grand Island Biological Co.) was employed in the fresh and/or heat-inactivated form in some experiments.
Cultures were established in triplicate or quadruplicate in final volumes of 1.0 ml, containing 5 X 105 lymphocytes, 20% autologous plasma or FCS, 0.05 ml FII, and 0.5% of 200 mM l-glutamine and antibiotics. Initial experiments employing concentrations of 50, 100, 200, 600, and 1,000 ,ug of agg-and deaggFII in 0.05-ml volumes indicated that 200 ,ug usually provided optimal in vitro mitogenic responses and, accordingly, all experiments reported herein were conducted in the presence of 200 ,ug FII (agg or deagg) /culture tube. In the majority of experiments, additional cultures containing fresh autologous plasma and 0.05 ml of a 1/10 dilution of phytohemagglutinin (PHA) (Difco Laboratories, Detroit, Mich.), added on the 3rd day of incubation, were established to ensure that cultured cells were capable of undergoing a mitogenic response. In some experiments, additional cultures were es- Table I (columns 3 and 4). The range of MI for eight RA subjects was 1.0-7.6 in the presence of aggFII and 0.7-2.4 in the presence of deaggFII. In the latter experiments, MI of 1.7 and 2.4 in the presence of deaggFII were encountered with two subjects; the preparations of deaggFII employed in these two experiments were found to consume more than 25% CHw0 units in native autologous plasma, thereby suggesting inadequate deaggregation of the FIT. One AS Effcct of aggFII on plasma C3 lcvels. Except for one normal subject, C3 concentrations were deternlined before and after the addition of 200 ,ug aggFII to plasma in all experiments (Table I, columns 5 and  6 ). For individual subjects and diagnostic groups no correlation was found between the degree of blastogenesis and the extent of C3 depletion by aggFII (Table I , columns 4 and 6). When the responses of the 15 subjects with enhanced blastogenesis (MI > 2.0) were compared to those of 11 subjects without such enhancement, it was found that the mean decrease in the level of plasma C3 after addition of aggFII was 0.31 mg/ml (range 0.07-0.81 mg/ml) for the former group and 0.18 mg/ml (range 0-0.45 mg/ml) for the latter (P < 0.1).
DISCUSSION The present studies demonstrate that the addition of 200 usg of aggFII, but not deaggFII to fresh autologous plasma was associated with enhanced in vitro blastogenic transformation of the peripheral blood lymphocytes of 15 of 27 subjects. Specifically, the mean response of the 15 subjects with MI of 2.0 or greater was 4.4, in comparison to a mean of 1.2 for the 12 subjects with indices of less than 2.0; the difference betwieen these means was highly significant statistically (P <0.001). In addition, by employing the same MI of 2.0 or greater to define enhanced blastogenesis, it was found that aggFII induced such enhancement with lymphocytes derived from 8 of 12 patients with RA, 5 of 6 with AS, 1 of 2 with SLE, and 1 of 7 normal subjects. Thus, the results of these studies indicate that in the presence of fresh autologous plasma, aggFII can induce significant transformation of the blood lymphocytes of some normal individuals and patients with immune arthropathies.
No statistically significant differences between the mean responses of the 7 normal subjects (mean MI= 1.6), the 12 patients with RA (mean MI = 2.9), and 2 patients with SLE (MI = 3.0 and 1.5) were found. Although lymphocytes of the AS patients did demonstrate a quantitatively greater mean response than those of the other study groups, other studies conducted in this laboratory and reported in abstract form indicate that AS lymphocytes, in comparison to normal and RA lymphocytes, also display greater in vitro blastogenesis in the mixed leukocyte reaction and in response to PHA (25 (29) and that B cells possess surface membrane receptors for C (18) and for immunoglobulins, including aggFII (30) . In view of these considerations, the results of the present studies suggest that the observed response to aggFII may have been mediated by B cells. In particular, the lack of correlation in the present studies between PHA and aggFII blastogenic responses for individual subjects would support such an interpretation, as would those studies which have demonstrated that B cells possess surface receptors for complement-fixing immune complexes (18) and for aggFII (30) . Thus, with respect to the present studies, it is attractive to speculate that complexes formed in vitro between aggFII with RF and/or C reacted with B cells bearing appropriate receptors and initiated the observed blastogenic sequence. Studies have been commenced which will directly evaluate this possibility.
The failure of deaggFII, which does not fix C (3), to induce blastogenesis in the presence of fresh autologous plasma suggests that participation of C may have been necessary for expression of the reaction described. This interpretation is augmented by those experiments in which it was demonstrated that both heat-inactivated plasma and FCS devoid of hemolytic complement were also unable to support aggFII-induced blastogenesis, Indeed, this requirement for fresh plasma may account for the negative results reported by previous investigators who employed heat-inactivated humiian A B sera (15) or calf sera (16) (31) and with current studies conducted by the author which demonstrate that, in fresh autologous plasma, activation of the alternate pathway of C by endotoxin, zymosan, and inulin initiates dose-dependent levels of in vitro blastogenesis of human lymphocytes in the absence of any mitogen (T. D. Kin- sella, unpublished observations).
In conclusion, the present studies suggest a mechanism whereby aggFII might assist in perpetuating the subsynovial lymphoid hyperplasia which is so characteristic of some immune arthropathies, such as RA. Various authors have demonstrated that aggFII is present in rheumatoid synovial fluids (7) , that activation and utilization of C occurs within the RA joint (4, 6) , and that intra-articular complexes of IgG and C are present in patients with RA (8) . Accordingly, although comparable information is not available for other immune arthropathies, studies of the intra-articular milieu in patients with RA have provided abundant evidence of the in vivo availability of substrates similar to those utilized in the present in vitro studies. By analogy with the present studies, therefore, the availability of C-fixing aggregated IgG in the RA joint might provoke in vivo intrasynovial lymphocyte transformation and persistent subsynovial lymphoid hyperplasia. Support for this concept can be derived from other studies conducted in this laboratory which have demonstrated that the majority of RA synovial fluids are mitogenic in vitro for autologous lymphocytes (24) . Although it is likely that the reaction described in the present studies is but a secondary phe-nomenon, and not the primary inducer of RA (or immune) synovitis, it is apparent that such a mechanism could conitribute to the propogation of chronic rheumatoid synovitis, with or without persistence of the primary inducer. In effect, these studies suggest that aggFII could support rheumatoid synovitis via cellular as well as humoral immune mechanisms.
Addendum. After this work was submitted, a paper by M. D. Reynolds and N. I. Abdou was published (1973. J. Clin. Invest. 52: 1627), which confirmed that aggregated gamma globulin can induce in vitro transformation of human lymphocytes.
